AVROBIO Financial Statements From 2010 to 2024

AVRODelisted Stock  USD 1.40  0.04  2.78%   
AVROBIO financial statements provide useful quarterly and yearly information to potential AVROBIO investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on AVROBIO financial statements helps investors assess AVROBIO's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting AVROBIO's valuation are summarized below:
AVROBIO does not now have any fundamental signals for analysis.
Check AVROBIO financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AVROBIO's main balance sheet or income statement drivers, such as , as well as many indicators such as . AVROBIO financial statements analysis is a perfect complement when working with AVROBIO Valuation or Volatility modules.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

AVROBIO Company Shares Owned By Insiders Analysis

AVROBIO's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current AVROBIO Shares Owned By Insiders

    
  1.65 %  
Most of AVROBIO's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AVROBIO is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 1.65% of AVROBIO are shares owned by insiders. This is 89.13% lower than that of the Biotechnology sector and 88.36% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 83.65% higher than that of the company.

AVROBIO Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AVROBIO's current stock value. Our valuation model uses many indicators to compare AVROBIO value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AVROBIO competition to find correlations between indicators driving AVROBIO's intrinsic value. More Info.
AVROBIO is number one stock in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AVROBIO's earnings, one of the primary drivers of an investment's value.

About AVROBIO Financial Statements

AVROBIO investors utilize fundamental indicators, such as revenue or net income, to predict how AVROBIO Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Avrobio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.

Pair Trading with AVROBIO

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AVROBIO position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVROBIO will appreciate offsetting losses from the drop in the long position's value.

Moving against AVROBIO Stock

  0.87HYMTF Hyundai MotorPairCorr
  0.84MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.81TLK Telkom Indonesia TbkPairCorr
  0.77EC Ecopetrol SA ADRPairCorr
  0.75SHG Shinhan FinancialPairCorr
The ability to find closely correlated positions to AVROBIO could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AVROBIO when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AVROBIO - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AVROBIO to buy it.
The correlation of AVROBIO is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AVROBIO moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AVROBIO moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AVROBIO can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Consideration for investing in AVROBIO Stock

If you are still planning to invest in AVROBIO check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AVROBIO's history and understand the potential risks before investing.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format